From the Editor
From the Editor
The antipsychiatry movement: Who and why
Although irritating, antipsychiatry helps keep us honest and rigorous about what we do
From the Editor
The model psychiatrist: 7 domains of excellence
Every psychiatrist can move from good to great with a modicum of effort and motivation
From the Editor
Quo vadis, psychopharmacology?
Innovation in psychopharmacology depends on overcoming multiple challenges that stifle drug discovery and development
From the Editor
Invisible tattoos: The stigmata of psychiatry
Stigma affects not just our patients, but also our profession
From the Editor
The most powerful placebo is not a pill
The psychiatrist’s verbal and nonverbal cues can have a positive or negative placebo effect on the patient
From the Editor
Harnessing epigenetics for psychiatry
Therapeutic orchestration of gene expression will one day prevent mental illness
From the Editor
A skeptical view of ‘progress’ in psychiatry
For psychiatry, progress isn’t what it used to be
From the Editor
Parsimonious pharmacotherapy
In some cases, a single psychotropic can effectively treat multiple disorders
From the Editor
Polypharmacy subtypes: The necessary, the reasonable, the ridiculous, and the hazardous
The spectrum of polypharmacy ranges from the rational to the irrational
From the Editor
Folie en masse! It’s so tempting to drink the Kool-Aid
It’s hard to resist endorsing widely accepted false beliefs
From the Editor
Two vastly underutilized interventions can improve schizophrenia outcomes
Wider use of clozapine and long-acting injectable antipsychotics can reduce the duration of untreated psychosis and improve quality of life